Search

everythinglearnresearchcommunity

for

Search:↓

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Anti-TNF therapy can cause hair loss and skin issues.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

A new treatment plan helps manage folliculitis decalvans effectively.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Dupilumab may worsen hair loss in patients with alopecia areata.

Proper guidelines are needed to prevent harmful steroid use in skin treatments.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Pregnancy can cause various skin changes, including pigmentation, acne, and stretch marks, and may affect preexisting skin conditions.

A woman's scalp condition improved with specific ointment after a hair piece caused skin issues.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

There is not enough evidence to recommend multivitamin-mineral supplements and herbal treatments for alopecia areata.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

COVID-19 may cause hair loss due to infection stress or treatments.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.